Trial Profile
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Choline alfoscerate (Primary) ; Choline alfoscerate
- Indications Cognition disorders
- Focus Pharmacokinetics
- Sponsors Hyundai Pharmaceutical
- 25 Mar 2015 New trial record